Case of the Month
Labs in the Netherlands are joining together to launch an AI model validation study for PD-L1 scoring with a goal of multi-source domain adaptation. Introduction Programmed death-ligand 1 (PDL1) is a protein that, when attached to T...
Webinar 25th of March, 2021 REGISTER NOW Source:...
Interview with Dr. Kati Mäkelä Kati Mäkelä, an MD specializing in pulmonary medicine at the Helsinki University Hospital and a PhD student in the Lung Factor Research Group in the University of Helsinki. Tell us about your research...
New Study – TissueCypher® Predicts Development of Esophageal ...
- Artificial Intelligence
- Business
- Case of the Month
- Clinical Laboratories
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- Image Analysis
- Informatics
- Laboratory Informatics
- Laboratory Management & Operations
- Medical Research
- New Digital Imaging Technologies
- Pathology News
- Publications
- Reports
- Science
- Vendor products
We are excited to announce a newly published clinical study of TissueCypher® performance for predicting development of esophageal cancer in patients with Non-dysplastic Barrett’s Esophagus. The study, Independent Validation of a Tissue...
The DeePathology AI Challenge !
- Artificial Intelligence
- Business
- Case of the Month
- Clinical Laboratories
- Clinical Pathology
- Data Management
- Device Manufacturers
- Digital Pathology News
- Education
- Informatics
- Laboratory Informatics
- Laboratory Information Systems
- Laboratory Management & Operations
- New Digital Imaging Technologies
- Pathology News
- Training
- Vendor products
- Web/Tech
- Webinars
DeePathology is in a mission to bring AI to the hands of every pathologist and biological sciences researchers ! Now, we invite you to challenge our DeePathology STUDIOTM ! DeePathology has developed the DeePathology STUDIOTM - a ‘Do It...
Feedbacks from hospitals in France, Canada and Belgium Dowload the White Paper Contents Many surgical procedures are being cancelled in this time of crisis, however cancer care must continue. Furthermore, cancer / COVID-19...